[EN] ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS<br/>[FR] DÉRIVÉS D'ISOQUINOLINONE EN TANT QU'ANTAGONISTES DES RÉCEPTEURS NK3
申请人:LUNDBECK & CO AS H
公开号:WO2010028655A1
公开(公告)日:2010-03-18
The invention relates to isoquinolinone derivatives useful in therapy, in particular in the treatment of psychosis, to compositions comprising said compounds, and to methods of treating diseases comprising the administration of said compounds.
[EN] ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS<br/>[FR] DÉRIVÉS D'ISOQUINOLINONE COMME ANTAGONISTES DU NK3
申请人:LUNDBECK & CO AS H
公开号:WO2010045948A1
公开(公告)日:2010-04-29
Isoquinolone derivatives of the general formula (I) are NK3 antagonists.
通式(I)的异喹啉衍生物是NK3拮抗剂。
Isoquinolinone derivatives as NK3 antagonists
申请人:H. Lundbeck A/S
公开号:US08173639B2
公开(公告)日:2012-05-08
Isoquinolone derivatives of the general formula
are provided. The compounds are NK3 antagonists and useful for the treatment of e.g. psychosis and schizophrenia.